Saturday, January 23, 2021

Bharat Biotech's Covaxin has tolerable safety, says Lancet study

Sharing the interim findings, the paper said that the vaccine was well tolerated in all dose groups with no vaccine-related adverse events

from Today's Paper https://ift.tt/3o9HgwU
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...